Media Spotlight
While earlier detection of breast cancer and continued improvements in therapy have led to decreasing mortality rates overall, today Black women experience a 41% higher death rate than White women as a result of breast cancer.
In an op-ed for the Philadelphia Inquirer, Dr. Christine Edmonds and PC3I Faculty Dr. Oluwadamilola “Lola” Fayanju share several ways in which Black women experience socioeconomic barriers and systemic biases that impact breast cancer treatment and survival. Severe underrepresentation of Black women in both clinical trials and the validation of risk assessment models only exacerbate disparities in diagnosis and prognosis. Furthermore, current mammographic screening recommendations discourage screening women ages 40-49, which disproportionately harms Black women, for whom diagnosis rates are comparatively higher under age 45.
In order to begin addressing these failures, Edmonds and Fayanju present several recommendations to both clinicians and patients, which are outlined in their Philadelphia Inquirer op-ed. Further coverage can be found on Newswise, HemOnc Today, Florida News Times, Wink News, CBS Atlanta, and CBS Miami.
Related News
Media Spotlight
PC3I Associate Director Lola Fayanju on Breast Cancer Screening Recommendations
09.27.2023
In an interview with the Philadelphia Inquirer, PC3I Associate Director Lola Fayanju commented on recently updated breast cancer screening recommendations.
Media Spotlight
Proton Therapy Study at Penn Medicine Gains New Attention
02.14.2023
As part of the RadComp study, Penn Medicine and over 20 radiation centers nationwide are comparing the effectiveness of photon therapy and proton therapy to treat breast cancer.
Media Spotlight
Machine Learning-Triggered Behavioral Nudges Quadrupled Serious Illness Conversation Rates
01.12.2023
A team led by PC3I Innovation Faculty Ravi Parikh has found that machine learning-triggered behavioral nudges quadrupled the rates of seriousness illness conversations for patients with advance cancer.